<DOC>
	<DOCNO>NCT01254981</DOCNO>
	<brief_summary>To perform randomized comparison Cypher Select+ stent Nobori stent treatment unselected patient ischaemic heart disease .</brief_summary>
	<brief_title>SORT-OUT V - Randomised Clinical Comparative Study Nobori Cypher Stent .</brief_title>
	<detailed_description>All patient treat one several drug-eluting coronary stent one four heart center Odense , Skejby , Aalborg Varde include study . All patient enrol study hospitalize one heart center mention . Patients recruit via advertisement . The study design non-inferiority study , objective prove Nobori Δ0 poorer maximum Cypher select+ . The nine-month event rate ( cardiac death , MI and/or TVR ) Cypher stent group SORT OUT 3 3.0 % The calculation power make follow assumption : P ( Cypher ) = 0.03 There good estimate event rate relate Nobori stent . α = 0.05 - one-sided 1-β = 0.80 Based various value Δ0 necessary number patient , N , group calculate ( StudySize Version 2.0.4 , Creostat ) : - Δ0 *N group - 0.0025 *57,589 - 0.005 *14,397 - 0.010 *3,599 - 0.015 *1,599 - 0.020 *900 According assumption , total 900 patient must include group order reject null hypothesis event rate Nobori group 2 percentage point ( 0.02 ) poor event rate Cypher group Nobori inferior Cypher , ( H0 : pNobori - pCypher ≥ Δ0 = 0.02 ) . The alternative hypothesis ( HA : pN - pS &lt; Δ0 ) provide Nobori non-inferior Cypher - select limit non-inferiority . Assuming inclusion rate 200 patient per month , possible include 2000 patient 10 month . Power almost 0.9 inclusion increase little 2400 . Organization The study head steer committee , PCI operator participate participate site . Evald Høj Christiansen , Aarhus , Principal Investigator . At present , member steer committee : Jens Flensted Lassen ( chairman ) , Leif Thuesen , Jan Ravkilde , Hans-Henrik Tilsted , Per Thayssen Lisette Okkels Jensen . All member steer committee give full access database take part interpretation data . The study secretariat randomization computer localize Department Cardiology , [ Hjertemedicinsk Afdeling ] , Aarhus University Hospital , Skejby .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>All patient eligible treatment one several drugeluting coronary stent one four heart center Odense , Skejby , Aalborg Varde include study . The patient treat accordance criterion applicable individual site . The indication use DES varies slightly four site , indication implantation DES base clinical angiographic criterion financial constraint apply individual site . Basically , DES choose instead BMS patient estimate increase risk restenosis , patient follow stenosis type : Long lesion , lesion small vessel , bifurcation , ostial lesion , instent restenoses stenosis proximal segment anterior descend branch . Furthermore , DES also choose diabetic leave main . The patient wish participate The patient participate randomize stent study Life expectancy &lt; 1 year Allergic Aspirin , clopidogrel , prasugrel ticlopidin Allergic sirolimus biolimus</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>DES</keyword>
	<keyword>Angina pectoris</keyword>
	<keyword>Stent</keyword>
</DOC>